Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer

Conditionally replicative adenoviruses (CRAds) were promising approach for solid tumour treatment, but its oncolytic efficiency and toxicity are still not satisfactory for further clinical application. Here, we developed the CAIX promotor (CAIX(promotor))‐controlled CRAd armed with a tumour suppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Dafei, Qiu, Dong, Zhang, Zichun, Yuchen Shi, Shang, Wang, Gang, Fang, Lin, Li, Huizhong, Li, Hailong, Tian, Hui, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521288/
https://www.ncbi.nlm.nih.gov/pubmed/32725966
http://dx.doi.org/10.1111/jcmm.15697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521288/
https://www.ncbi.nlm.nih.gov/pubmed/32725966
http://dx.doi.org/10.1111/jcmm.15697

Ejemplares similares